本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BriaCell Therapeutics Corp.

0.7720
-1.2480-61.78%
盘前0.84000.0680+8.81%07:14 EDT
成交量:2,376.58万
成交额:3,602.94万
市值:523.11万
市盈率:-0.11
高:2.02
开:1.97
低:0.6900
收:2.02
数据加载中...
2021/08/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/06/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/15

招股说明书

F-1 - Registration statement for certain foreign private issuers
2021/06/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/02

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/18

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/18

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/18

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/18

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/03

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/15

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/14

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/23

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/12/22

SEC问询函

CORRESP [Cover] - Correspondence